DOPAMINE AGONISTS IN PARKINSONS-DISEASE - LATEST PHARMACOLOGICAL AND CLINICAL FINDINGS, ASPECTS AND PROBLEMS

被引:2
|
作者
HOROWSKI, R
机构
关键词
D O I
10.1055/s-2007-1020847
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:167 / 172
页数:6
相关论文
共 50 条
  • [31] DOPAMINE, TREMOR, AND PARKINSONS-DISEASE
    HIRSCH, EC
    MOUATT, A
    FAUCHEUX, B
    BONNET, AM
    JAVOYAGID, F
    GRAYBIEL, AM
    AGID, Y
    LANCET, 1992, 340 (8811): : 125 - 126
  • [32] PARKINSONS-DISEASE, DOPAMINE, AND PERSONALITY
    MENZA, M
    FORMAN, NE
    GOLDSTEIN, HE
    GOLBE, LI
    ANNALS OF NEUROLOGY, 1989, 26 (01) : 125 - 125
  • [33] DOPAMINERGIC AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
    GOETZ, CG
    DIEDERICH, NJ
    NEUROLOGIC CLINICS, 1992, 10 (02) : 527 - 540
  • [34] DOPAMINERGIC AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
    GOETZ, CG
    NEUROLOGY, 1990, 40 (10) : 50 - 54
  • [35] CLINICAL, NEUROCHEMICAL AND THERAPEUTIC ASPECTS OF DEPRESSION IN PARKINSONS-DISEASE
    MECO, G
    FABRIZIO, E
    GASPARINI, M
    GIUSTINI, P
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1994, 16 (03): : 65 - 74
  • [36] CLINICAL AND BIOCHEMICAL ASPECTS IN EARLY ONSET OF PARKINSONS-DISEASE
    DEYEBENES, JG
    BAZAN, E
    MENA, MA
    MURADAS, V
    REIRIZ, J
    ROMERO, J
    GONZALEZELIPE, J
    REVISTA CLINICA ESPANOLA, 1986, 178 (07): : 343 - 346
  • [37] NEUROUROLOGIC FINDINGS IN PARKINSONS-DISEASE
    PAVLAKIS, AJ
    SIROKY, MB
    GOLDSTEIN, I
    KRANE, RJ
    JOURNAL OF UROLOGY, 1983, 129 (01): : 80 - 83
  • [38] IMPROVEMENT IN ADVANCED PARKINSONS-DISEASE WITH LARGER LESS FREQUENT DOSES OF DOPAMINE AGONISTS
    GRIMES, JD
    HASSAN, MN
    PAYNE, LW
    GRAY, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) : 197 - 197
  • [39] VARIABILITY IN PARKINSONS-DISEASE - CLINICAL ASPECTS, CAUSES AND TREATMENT
    PARKES, JD
    ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 : 27 - 35
  • [40] DOPAMINE-RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
    CHASE, TN
    METMAN, LV
    BRAVI, D
    ROBERTS, JW
    SIBLEY, DR
    MOURADIAN, MM
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S207 - S215